Factbox-Anthropic’s public benefit fund and how it compares with other big philanthropic efforts Investing.com · News 23m ago
Guggenheim raises Rapport Therapeutics price target to $70 on trial data Investing.com · News 25m ago
General Mills Stock Is Down 30%, and Wall Street Analysts Keep Cutting Their Price Targets. Here's Why History Says They're Missing the Bigger Picture. NASDAQ · Markets 37m ago
ACCESS Newswire at LD Micro event: growth plan shifts to recurring revenue Investing.com · News 37m ago